GlassScriptPhysician profile
William M Healy
NPI 1730137795
$1,073.47
in general payments reported to CMS, 2019-2025
19 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $45.75 · 2021: $23.55 · 2022: $220 · 2023: $262 · 2024: $124 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $219.29 | 2019-2025 | Zerbaxa, Pifeltro, Delstrigo |
| Janssen Biotech, INC. | $190.97 | 2021-2023 | Symtuza |
| Astellas Pharma US INC | $96.83 | 2019-2025 | Cresemba |
| Solventum Corporation | $71.29 | 2025 | Activ.A.C. |
| Aimmune Therapeutics, INC. | $65.76 | 2024 | |
| Baxter Healthcare | $64.79 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Gilead Sciences, INC. | $46.03 | 2019-2022 | |
| Shionogi INC | $41.30 | 2022-2024 | Fetroja |
| Axsome Therapeutics, INC. | $37.97 | 2023 | Auvelity |
| Ethicon INC. | $33.92 | 2025 | Monarch Platform |
| Melinta Therapeutics, LLC | $33.13 | 2019 | |
| Smith+Nephew, INC. | $31.56 | 2022 | |
| Viiv Healthcare Company | $30.81 | 2025 | Cabenuva |
| Paratek Pharmaceuticals, INC. | $29.33 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $19.54 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $17.77 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.80 | 2023 | Rebyota |
| Janssen Pharmaceuticals, INC | $14.05 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.